Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: SLC6A1-NDD Prospective Longitudinal Natural History Study

View source ↗

Summary

This clinical trial update describes a prospective longitudinal natural history study of SLC6A1-related neurodevelopmental disorder and related developmental an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: UCB Biopharma SRL | Conditions: SLC6A1 Neurodevelopmental Disorder (NDD), Developmental and Epileptic Encephalopathies | Status: NOT_YET_RECRUITING